HLS Therapeutics (HLS) Competitors C$4.20 -0.05 (-1.18%) As of 04/17/2025 03:35 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock HLS vs. ACB, FIRE, EPI, ICC, RIV, CPH, LEAF, WEED, OGI, and RXShould you be buying HLS Therapeutics stock or one of its competitors? The main competitors of HLS Therapeutics include Aurora Cannabis (ACB), Supreme Cannabis (FIRE), ESSA Pharma (EPI), ICC Labs (ICC), RIV Capital (RIV), Cipher Pharmaceuticals (CPH), Leaf Mobile (LEAF), Canopy Growth (WEED), Organigram (OGI), and BioSyent (RX). These companies are all part of the "drug manufacturers - specialty & generic" industry. HLS Therapeutics vs. Aurora Cannabis Supreme Cannabis ESSA Pharma ICC Labs RIV Capital Cipher Pharmaceuticals Leaf Mobile Canopy Growth Organigram BioSyent HLS Therapeutics (TSE:HLS) and Aurora Cannabis (TSE:ACB) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, community ranking, analyst recommendations, earnings, media sentiment, risk, institutional ownership, valuation and profitability. Is HLS or ACB more profitable? Aurora Cannabis has a net margin of -22.55% compared to HLS Therapeutics' net margin of -38.70%. Aurora Cannabis' return on equity of -8.36% beat HLS Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets HLS Therapeutics-38.70% -25.27% -2.89% Aurora Cannabis -22.55%-8.36%-1.87% Do analysts recommend HLS or ACB? HLS Therapeutics currently has a consensus price target of C$4.50, indicating a potential upside of 7.14%. Aurora Cannabis has a consensus price target of C$8.75, indicating a potential upside of 42.51%. Given Aurora Cannabis' stronger consensus rating and higher possible upside, analysts plainly believe Aurora Cannabis is more favorable than HLS Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HLS Therapeutics 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Aurora Cannabis 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 2 Strong Buy rating(s) 3.33 Do insiders and institutionals believe in HLS or ACB? 65.2% of HLS Therapeutics shares are owned by institutional investors. Comparatively, 13.4% of Aurora Cannabis shares are owned by institutional investors. 0.4% of HLS Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more volatility & risk, HLS or ACB? HLS Therapeutics has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 2.71, suggesting that its share price is 171% more volatile than the S&P 500. Which has stronger earnings & valuation, HLS or ACB? HLS Therapeutics has higher earnings, but lower revenue than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than HLS Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHLS TherapeuticsC$40.13M2.33-C$15.53M-C$1.00-4.21Aurora CannabisC$195.83M1.72-C$44.16M-C$0.81-7.58 Does the MarketBeat Community favor HLS or ACB? Aurora Cannabis received 497 more outperform votes than HLS Therapeutics when rated by MarketBeat users. However, 64.15% of users gave HLS Therapeutics an outperform vote while only 63.14% of users gave Aurora Cannabis an outperform vote. CompanyUnderperformOutperformHLS TherapeuticsOutperform Votes3464.15% Underperform Votes1935.85% Aurora CannabisOutperform Votes53163.14% Underperform Votes31036.86% Does the media refer more to HLS or ACB? In the previous week, Aurora Cannabis had 1 more articles in the media than HLS Therapeutics. MarketBeat recorded 1 mentions for Aurora Cannabis and 0 mentions for HLS Therapeutics. HLS Therapeutics' average media sentiment score of 0.59 beat Aurora Cannabis' score of 0.00 indicating that HLS Therapeutics is being referred to more favorably in the media. Company Overall Sentiment HLS Therapeutics Positive Aurora Cannabis Neutral SummaryAurora Cannabis beats HLS Therapeutics on 11 of the 18 factors compared between the two stocks. Get HLS Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HLS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HLS vs. The Competition Export to ExcelMetricHLS TherapeuticsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$93.44MC$2.13BC$5.30BC$5.52BDividend Yield4.30%2.92%5.45%6.83%P/E Ratio-4.214.3321.8629.92Price / Sales2.33478.32380.59567.99Price / Cash15.2210.2538.2683.20Price / Book1.676.146.453.53Net Income-C$15.53MC$20.70BC$3.22BC$300.83M1 Month Performance-4.55%-3.01%-9.71%-3.70%1 Year Performance-15.15%93.89%11.52%11.14% HLS Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HLSHLS Therapeutics0.4231 of 5 starsC$4.20-1.2%C$4.50+7.1%-14.6%C$93.44MC$40.13M-4.2191News CoverageACBAurora Cannabis1.3953 of 5 starsC$5.50-4.3%C$8.75+59.1%-31.9%C$300.90MC$195.83M-6.791,073FIRESupreme CannabisN/AN/AN/AN/AC$259.40MC$53.29M-10.97400EPIESSA PharmaN/AC$8.20+7.2%N/A+0.0%C$237.87MN/A-8.2725ICCICC LabsN/AC$1.62-5.8%N/A+0.0%C$223.64MC$533,684.0095.29N/AGap UpRIVRIV CapitalN/AN/AN/AN/AC$213.65MC$11.33M-1.6312News CoverageCPHCipher Pharmaceuticals1.1431 of 5 starsC$11.20-3.7%C$14.75+31.7%+35.4%C$201.08MC$19.03M12.375LEAFLeaf MobileN/AN/AN/AN/AC$198.42MC$83.74M58.86150WEEDCanopy Growth1.4628 of 5 starsC$1.17-11.4%C$5.64+381.9%-84.9%C$188.22MC$519.68M-0.172,700OGIOrganigram2.7704 of 5 starsC$1.27-5.2%C$3.67+188.7%-42.9%C$156.90MC$180.58M-2.68987RXBioSyentN/AC$10.05-1.0%N/A+24.3%C$114.95MC$34.06M16.31N/ANews Coverage Related Companies and Tools Related Companies Aurora Cannabis Competitors Supreme Cannabis Competitors ESSA Pharma Competitors ICC Labs Competitors RIV Capital Competitors Cipher Pharmaceuticals Competitors Leaf Mobile Competitors Canopy Growth Competitors Organigram Competitors BioSyent Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:HLS) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HLS Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HLS Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
